Advertisement

The Impact of Revascularization on Mortality in Patients with Nonacute Coronary Artery Disease

      Abstract

      Background

      Although early revascularization improves outcomes for patients with acute coronary syndromes, the role of revascularization for patients with nonacute coronary artery disease is controversial. The objective of this meta-analysis was to compare surgical or percutaneous revascularization with medical therapy alone to determine the impact of revascularization on death and nonfatal myocardial infarction in patients with coronary artery disease.

      Methods

      The Medline and Cochrane Central Register of Controlled Trials databases were searched to identify randomized trials of coronary revascularization (either surgical or percutaneous) versus medical therapy alone in patients with nonacute coronary disease reporting the individual outcomes of death or nonfatal myocardial infarction reported at a minimum follow-up of 1 year. A random effects model was used to calculate odds ratios (OR) for the 2 prespecified outcomes.

      Results

      Twenty-eight studies published from 1977 to 2007 were identified for inclusion in the analysis; the revascularization modality was percutaneous coronary intervention in 17 studies, coronary bypass grafting in 6 studies, and either strategy in 5 studies. Follow-up ranged from 1 to 10 years with a median of 3 years. The 28 trials enrolled 13,121 patients, of whom 6476 were randomized to revascularization and 6645 were randomized to medical therapy alone. The OR for revascularization versus medical therapy for mortality was 0.74 (95% confidence interval [CI], 0.63-0.88). A stratified analysis according to revascularization mode revealed both bypass grafting (OR 0.62; 95% CI, 0.50-0.77) and percutaneous intervention (OR 0.82; 95% CI, 0.68-0.99) to be superior to medical therapy with respect to mortality. Revascularization was not associated with a significant reduction in nonfatal myocardial infarction compared with medical therapy (OR 0.91; 95% CI, 0.72-1.15).

      Conclusion

      Revascularization by coronary bypass surgery or percutaneous intervention in conjunction with medical therapy in patients with nonacute coronary artery disease is associated with significantly improved survival compared with medical therapy alone.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Braunwald E.
        • Antman E.M.
        • Beasley J.W.
        • et al.
        ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction—summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina).
        J Am Coll Cardiol. 2002; 40: 1366-1374
        • Davies R.F.
        • Goldberg A.D.
        • Forman S.
        • et al.
        Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization.
        Circulation. 1997; 95: 2037-2043
        • Madsen J.K.
        • Grande P.
        • Saunamaki K.
        • et al.
        Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI).
        Circulation. 1997; 96: 748-755
        • Yusuf S.
        • Zucker D.
        • Peduzzi P.
        • et al.
        Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration.
        Lancet. 1994; 344: 563-570
        • Alderman E.L.
        • Bourassa M.G.
        • Cohen L.S.
        • et al.
        Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study.
        Circulation. 1990; 82: 1629-1646
        • European Coronary Surgery Study Group
        Coronary-artery bypass surgery in stable angina pectoris: survival at two years.
        Lancet. 1979; 1: 889-893
      1. Myocardial infarction and mortality in the coronary artery surgery study (CASS) randomized trial.
        N Engl J Med. 1984; 310: 750-758
      2. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial.
        Lancet. 1997; 350: 461-468
      3. Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial.
        Lancet. 2001; 358: 951-957
        • Boden W.E.
        • O'Rourke R.A.
        • Teo K.K.
        • et al.
        Optimal medical therapy with or without PCI for stable coronary disease.
        N Engl J Med. 2007; 356: 1503-1516
        • Katritsis D.G.
        • Ioannidis J.P.
        Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis.
        Circulation. 2005; 111 (2612): 2906
        • Bakhai A.
        • Hill R.A.
        • Dundar Y.
        • et al.
        Percutaneous transluminal coronary angioplasty with stents versus coronary artery bypass grafting for people with stable angina or acute coronary syndromes.
        Cochrane Database Syst Rev. 2005; (CD004588)
      4. Coronary angioplasty versus coronary artery bypass surgery: the Randomized Intervention Treatment of Angina (RITA) trial.
        Lancet. 1993; 341: 573-580
        • Hamm C.W.
        • Reimers J.
        • Ischinger T.
        • et al.
        A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease.
        N Engl J Med. 1994; 331: 1037-1043
        • King 3rd, S.B.
        • Lembo N.J.
        • Weintraub W.S.
        • et al.
        A randomized trial comparing coronary angioplasty with coronary bypass surgery.
        N Engl J Med. 1994; 331: 1044-1050
        • The Bypass Angioplasty Revascularization Investigation (BARI) Investigators
        Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease.
        N Engl J Med. 1996; 335: 217-225
        • Serruys P.W.
        • Unger F.
        • Sousa J.E.
        • et al.
        Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease.
        N Engl J Med. 2001; 344: 1117-1124
        • Bravata D.M.
        • Gienger A.L.
        • McDonald K.M.
        • et al.
        Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass surgery.
        Ann Intern Med. 2007; 147: 703-716
        • Rosenberg M.S.
        The file-drawer problem revisited: a general weighted method for calculating fail-safe numbers in meta-analysis.
        Int J Org Evol. 2005; 59: 464-468
        • Hueb W.A.
        • Bellotti G.
        • de Oliveira S.A.
        • et al.
        The Medicine, Angioplasty or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses.
        J Am Coll Cardiol. 1995; 26: 1600-1605
        • Hueb W.
        • Lopes N.H.
        • Gersh B.J.
        • et al.
        Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
        Circulation. 2007; 115: 1082-1089
        • Yousef Z.R.
        • Redwood S.R.
        • Bucknall C.A.
        • et al.
        Late intervention after anterior myocardial infarction: effects on left ventricular size, function, quality of life, and exercise tolerance: results of the Open Artery Trial (TOAT Study).
        J Am Coll Cardiol. 2002; 40: 869-876
        • Steg P.G.
        • Thuaire C.
        • Himbert D.
        • et al.
        DECOPI (DEsobstruction COronaire en Post-Infarctus): a randomized multi-centre trial of occluded artery angioplasty after acute myocardial infarction.
        Eur Heart J. 2004; 25: 2187-2194
        • Hochman J.S.
        • Lamas G.A.
        • Buller C.E.
        • et al.
        Coronary intervention for persistent occlusion after myocardial infarction.
        N Engl J Med. 2006; 355: 2395-2407
        • Serruys P.W.
        • Ong A.T.
        • van Herwerden L.A.
        • et al.
        Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial.
        J Am Coll Cardiol. 2005; 46: 575-581
        • Gibbons R.J.
        • Abrams J.
        • Chatterjee K.
        • et al.
        ACC/AHA 2002 guideline update for the management of patients with chronic stable angina—summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina).
        J Am Coll Cardiol. 2003; 41: 159-168
        • Hambrecht R.
        • Walther C.
        • Mobius-Winkler S.
        • et al.
        Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial.
        Circulation. 2004; 109: 1371-1378
        • Mathur V.S.
        • Guinn G.A.
        Prospective randomized study of the surgical therapy of stable angina.
        Cardiovasc Clin. 1977; 8: 131-144
        • Kloster F.E.
        • Kremkau E.L.
        • Ritzmann L.W.
        • et al.
        Coronary bypass for stable angina: a prospective randomized study.
        N Engl J Med. 1979; 300: 149-157
        • Norris R.M.
        • Agnew T.M.
        • Brandt P.W.
        • et al.
        Coronary surgery after recurrent myocardial infarction: progress of a trial comparing surgical with nonsurgical management for asymptomatic patients with advanced coronary disease.
        Circulation. 1981; 63: 785-792
        • The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group
        Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina.
        N Engl J Med. 1984; 311: 1333-1339
        • Parisi A.F.
        • Folland E.D.
        • Hartigan P.
        A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease.
        N Engl J Med. 1992; 326: 10-16
        • Hartigan P.M.
        • Giacomini J.C.
        • Folland E.D.
        • Parisi A.F.
        Two- to three-year follow-up of patients with single-vessel coronary artery disease randomized to PTCA or medical therapy (results of a VA cooperative study).
        Am J Cardiol. 1998; 82: 1445-1450
        • Ellis S.G.
        • Mooney M.R.
        • George B.S.
        • et al.
        Randomized trial of late elective angioplasty versus conservative management for patients with residual stenoses after thrombolytic treatment of myocardial infarction.
        Circulation. 1992; 86: 1400-1406
        • Sievers N.
        • Hamm C.W.
        • Herzner A.
        • Kuck K.H.
        Medical therapy versus PTCA: a prospective, randomized trial in patients with asymptomatic coronary single-vessel disease.
        Circulation. 1993; 88 (abstract): I-297
        • Folland E.D.
        • Hartigan P.M.
        • Parisi A.F.
        Percutaneous transluminal coronary angioplasty versus medical therapy for stable angina pectoris: outcomes for patients with double-vessel versus single-vessel coronary artery disease in a Veterans Affairs Cooperative randomized trial.
        J Am Coll Cardiol. 1997; 29: 1505-1511
        • Dakik H.A.
        • Kleiman N.S.
        • Farmer J.A.
        • et al.
        Intensive medical therapy versus coronary angioplasty for suppression of myocardial ischemia in survivors of acute myocardial infarction: a prospective, randomized pilot study.
        Circulation. 1998; 98: 2017-2023
        • Horie H.
        • Takahashi M.
        • Minai K.
        • et al.
        Long-term beneficial effect of late reperfusion for acute anterior myocardial infarction with percutaneous transluminal coronary angioplasty.
        Circulation. 1998; 98: 2377-2382
        • Pitt B.
        • Waters D.
        • Brown W.V.
        • et al.
        Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease.
        N Engl J Med. 1999; 341: 70-76
        • Jeger R.V.
        • Bonetti P.O.
        • Zellweger M.J.
        • et al.
        Influence of revascularization on long-term outcome in patients>or =75 years of age with diabetes mellitus and angina pectoris.
        Am J Cardiol. 2005; 96: 193-198
        • Bech G.J.
        • De Bruyne B.
        • Pijls N.H.
        • et al.
        Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial.
        Circulation. 2001; 103: 2928-2934
        • Zeymer U.
        • Uebis R.
        • Vogt A.
        • et al.
        Randomized comparison of percutaneous transluminal coronary angioplasty and medical therapy in stable survivors of acute myocardial infarction with single vessel disease: a study of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte.
        Circulation. 2003; 108: 1324-1328
        • Hueb W.
        • Soares P.R.
        • Gersh B.J.
        • et al.
        The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results.
        J Am Coll Cardiol. 2004; 43: 1743-1751
        • Mahmarian J.J.
        • Dakik H.A.
        • Filipchuk N.G.
        • et al.
        An initial strategy of intensive medical therapy is comparable to that of coronary revascularization for suppression of scintigraphic ischemia in high-risk but stable survivors of acute myocardial infarction.
        J Am Coll Cardiol. 2006; 48: 2458-2467
        • Erne P.
        • Schoenenberger A.W.
        • Burckhardt D.
        • et al.
        Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial.
        JAMA. 2007; 297: 1985-1991